High-dose oral linezolid achieved rapid clinical and microbiological recovery in a severely overweight male with long-standing infected ulcers

J Antimicrob Chemother. 2019 Jun 1;74(6):1755-1757. doi: 10.1093/jac/dkz071.

Authors

Haresh Selvaskandan¹, Deborah E Modha², Ruth Denton-Beaumont¹, Corrine Ashton³, Ryan A Hamilton³

Affiliations

¹ Department of Acute Medicine, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK.
² Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, UK.
³ Department of Pharmacy, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK.

PMID: 30783670
DOI: 10.1093/jac/dkz071

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Bacterial Agents / administration & dosage*
Anti-Bacterial Agents / pharmacokinetics
Cellulitis / complications
Cellulitis / diagnosis
Cellulitis / drug therapy
Cellulitis / microbiology
Humans
Linezolid / administration & dosage*
Linezolid / pharmacokinetics
Male
Obesity / complications*
Treatment Outcome
Ulcer / complications*
Ulcer / diagnosis
Ulcer / drug therapy*
Ulcer / microbiology

Substances

Anti-Bacterial Agents
Linezolid